#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3537730	A	Drug level in cynomolgus monkey urine treated with [14C]brivanib alaninate at 10 mg/kg, po administered as single dose via gavage by mass spectrometry	Macaca fascicularis	2	ALA3526109	organism-based format	Scientific Literature
2.	ALA3537733	A	Drug uptake in human plasma treated with [14C]brivanib alaninate assessed as AUC (0 to 12 hrs) of total radio activity at 800 mg, po administered as single oral dose by HPLC analysis	Homo sapiens	6	ALA3526109	organism-based format	Scientific Literature
3.	ALA3540344	A	Drug level in Sprague-Dawley rat plasma assessed as compound formation treated with [14C]brivanib alaninate at 100 mg/kg, po administered as single dose via gavage measured after 1 hr by HPLC analysis	Rattus norvegicus	10	ALA3526109	organism-based format	Scientific Literature
4.	ALA3540345	A	Drug level in Sprague-Dawley rat plasma assessed as compound formation treated with [14C]brivanib alaninate at 100 mg/kg, po administered as single dose via gavage measured after 2 hrs by HPLC analysis	Rattus norvegicus	10	ALA3526109	organism-based format	Scientific Literature
5.	ALA3540346	A	Drug level in Sprague-Dawley rat plasma assessed as compound formation treated with [14C]brivanib alaninate at 100 mg/kg, po administered as single dose via gavage measured after 6 hrs by HPLC analysis	Rattus norvegicus	10	ALA3526109	organism-based format	Scientific Literature
6.	ALA3540347	A	Drug level in cynomolgus monkey plasma assessed as compound formation treated with [14C]brivanib alaninate at 10 mg/kg, po administered as single dose via gavage measured after 1 hr by HPLC analysis	Macaca fascicularis	10	ALA3526109	organism-based format	Scientific Literature
7.	ALA3540348	A	Drug level in cynomolgus monkey plasma assessed as compound formation treated with [14C]brivanib alaninate at 10 mg/kg, po administered as single dose via gavage measured after 2 hrs by HPLC analysis	Macaca fascicularis	10	ALA3526109	organism-based format	Scientific Literature
8.	ALA3540349	A	Drug level in cynomolgus monkey plasma assessed as compound formation treated with [14C]brivanib alaninate at 10 mg/kg, po administered as single dose via gavage measured after 4 hrs by HPLC analysis	Macaca fascicularis	10	ALA3526109	organism-based format	Scientific Literature
9.	ALA3540350	A	Drug level in cynomolgus monkey plasma assessed as compound formation treated with [14C]brivanib alaninate at 10 mg/kg, po administered as single dose via gavage measured after 6 hrs by HPLC analysis	Macaca fascicularis	11	ALA3526109	organism-based format	Scientific Literature
10.	ALA3540351	A	Drug level in cynomolgus monkey plasma assessed as compound formation treated with [14C]brivanib alaninate at 10 mg/kg, po administered as single dose via gavage measured after 12 hrs by HPLC analysis	Macaca fascicularis	11	ALA3526109	organism-based format	Scientific Literature
11.	ALA3540352	A	Drug level in human plasma assessed as compound formation treated with [14C]brivanib alaninate at 800 mg, po administered as single dose via gavage measured after 1 hr by HPLC analysis	Homo sapiens	11	ALA3526109	organism-based format	Scientific Literature
12.	ALA3540353	A	Drug level in human plasma assessed as compound formation treated with [14C]brivanib alaninate at 800 mg, po administered as single dose via gavage measured after 2 hrs by HPLC analysis	Homo sapiens	11	ALA3526109	organism-based format	Scientific Literature
13.	ALA3540354	A	Drug uptake in cynomolgus monkey plasma treated with [14C]brivanib alaninate assessed as AUC (0 to 4 hrs) of total radio activity at 10 mg/kg, po administered as single oral dose by HPLC analysis	Macaca fascicularis	1	ALA3526109	organism-based format	Scientific Literature
14.	ALA3540356	A	Drug uptake in Sprague-Dawley rat plasma treated with [14C]brivanib alaninate assessed as AUC (0 to 6 hrs) of total radio activity at 100 mg/kg, po administered as single oral dose by HPLC analysis	Rattus norvegicus	6	ALA3526109	organism-based format	Scientific Literature
15.	ALA3538179	A	Drug level in human plasma assessed as compound formation treated with [14C]brivanib alaninate at 800 mg, po administered as single dose via gavage measured after 4 hrs by HPLC analysis	Homo sapiens	11	ALA3526109	organism-based format	Scientific Literature
16.	ALA3538180	A	Drug level in human plasma assessed as compound formation treated with [14C]brivanib alaninate at 800 mg, po administered as single dose via gavage measured after 8 hrs by HPLC analysis	Homo sapiens	11	ALA3526109	organism-based format	Scientific Literature
17.	ALA3538181	A	Drug level in human plasma assessed as compound formation treated with [14C]brivanib alaninate at 800 mg, po administered as single dose via gavage measured after 12 hrs by HPLC analysis	Homo sapiens	11	ALA3526109	organism-based format	Scientific Literature
18.	ALA3538182	A	AUC (0 to 6 hrs) Sprague-Dawley rat plasma treated with [14C]brivanib alaninate at 100 mg/kg, po administered as single oral dose by HPLC analysis	Rattus norvegicus	6	ALA3526109	organism-based format	Scientific Literature
19.	ALA3538184	A	AUC (0 to 4 hrs) cynomolgus monkey plasma treated with [14C]brivanib alaninate at 10 mg/kg, po administered as single oral dose by HPLC analysis	Macaca fascicularis	1	ALA3526109	organism-based format	Scientific Literature
20.	ALA3538185	A	AUC (0 to 12 hrs) human plasma treated with [14C]brivanib alaninate at 800 mg, po administered as single oral dose by HPLC analysis	Homo sapiens	6	ALA3526109	organism-based format	Scientific Literature